NCT06085963View on ClinicalTrials.gov

Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Allergic Rhinitis Due to Pollen
Interventions
DRUG

ITULAZAX 12 SQ-Bet

Active ingredients: Birch (Betula verrucosa) extracts Dosage form: Oral lyophilisate (referred to as allergy immunotherapy tablet in text) Dose/strength: 12 SQ-Bet Excipients: Gelatine (fish source), mannitol and sodium hydroxide

DRUG

Placebo tablet

Active ingredients: None Dosage form: Oral lyophilisate (referred to as allergy immunotherapy tablet in text) Excipients: Gelatine (fish source), mannitol and sodium hydroxide

DRUG

Nacl

Sodium chloride solution 9mg/ml

Trial Locations (1)

17176

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER